Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05671198

Sonographic Diaphragm Function in AECOPD

Ultrasound of the Diaphragm As Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
51 (estimated)
Sponsor
Isala · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will be conducted as a single-center, prospective cohort study. The primary objective of this study is to investigate the responsiveness of sonographic parameters of diaphragm to detect change in Borg score for dyspnea during hospitalisation for AECOPD without respiratory acidosis.

Detailed description

To investigate the responsiveness of sonographic parameters to detect change in Borg score for dyspnea during hospitalisation for AECOPD without respiratory acidosis, we propose a prospective cohort design. After inclusion, participants will have assessment of diaphragm function (excursion, thickness, thickening fraction) using ultrasound within 48 hours of admission to the emergency ward, striving to assessment within 24 hours of admission. Additionally, dyspnea grade will be assessed using validated questionnaires. Further diagnostic work-up and treatment for AECOPD is performed at the discretion of the treating physician. Both ultrasound measurements and dyspnea grade questionnaires will be repeated when the participant is reported suitable for hospital discharge by the treating physician.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound of the diaphragmSonographic parameters of the diaphragm: * Thickening Fraction (TF); (Diaphragm thickness end-inspiration- Diaphragm thickness end-expiration) / Diaphragm thickness end-expiration. (continuous variable). * Diaphragm end-expiratory thickness: Diaphragm thickness at end-expiration (continuous variable) * Diaphragm excursion (DE): diaphragm inspiratory amplitude during deep breathing (continuous variable).

Timeline

Start date
2023-03-27
Primary completion
2025-03-01
Completion
2025-08-01
First posted
2023-01-04
Last updated
2024-10-04

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05671198. Inclusion in this directory is not an endorsement.